CCME Global Limited announces Q2 FY27 results and acquisition completions
CCME Global · Pharmaceuticals & Biotechnology
Key highlights
- Reported net loss of ₹48.18 lakh for half year ended September 30, 2026; EPS (basic and diluted) at (₹0.11)
- Completed acquisition of 51% stake in Cash & Carry Middle East FZCO on November 14, 2026, via share swap and cash consideration totaling ₹127.50 crore
- Completed acquisition of 52% stake in Interlink Distribution LLC on October 28, 2026, via share swap consideration of ₹20.34 crore
Original filing
Board Meeting Outcome for Outcome Of Board Meeting Held On November 14, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from CCME Global
- Acquisition / mergerCCME Global Limited reports Q2 FY2027 results and completion of two acquisitions
- Fundraise / allotmentMajor developmentCCME Global Limited announces allotment of shares for acquisitions and preferential issues
- Fundraise / allotmentMajor developmentCCME Global allots 15,08,42,244 shares; Interlink a subsidiary, CCME UAE an associate
Other acquisition / merger filings this fortnight
- Acquisition / mergerL. T. ElevatorL.T. Elevator reports H1 FY27 revenue ₹71.4 Cr and PAT ₹10.3 Cr, EBITDA margin 22.4%
- Acquisition / mergerKaynes Technology IndiaKaynes Technology India Ltd reports Q2 FY27 financials and subsidiary strike-off plans
- Acquisition / merger5paisa Capital5paisa Capital Limited completes acquisition of Giskard Datatech Private Limited
- Acquisition / mergerKS Smart TechnlogiesKS Smart Technologies Ltd approves Scheme of Amalgamation with wholly owned subsidiary
- Acquisition / mergerAirfloa Rail TechnologyAirfloa Rail Technology Ltd signs asset acquisition agreement with KIN Railway Equipment
- Acquisition / mergerSejal GlassSejal Glass Limited executes Business Transfer Agreement to acquire glass business
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.